This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v4.0.0-ballot: STU4 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 3.0.0. For a full list of available versions, see the Directory of published versions
Generated Narrative: MedicationAdministration
Resource MedicationAdministration "cancer-related-medication-admin-idarubicin-brian-l"
Normalization Basis Extension: Body surface area (observable entity) (SNOMED CT#301898006)
status: completed
category: Inpatient (MedicationRequest Category Codes#inpatient)
medication: IDArubicin (RxNorm#5650)
subject: Patient/cancer-patient-brian-l " L"
effective: 2024-01-09
Actor |
Practitioner/us-core-practitioner-nancy-oncology-nurse " NURSE" |
reasonReference: Condition/primary-cancer-condition-brian-l
request: MedicationRequest/cancer-related-medication-request-idarubicin-brian-l
note: IDArubicin (c), 5.4mg. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2024-01-09)
Route | Dose |
Intravenous route (qualifier value) (SNOMED CT#47625008) | 5.4 mg (Details: UCUM code mg = 'mg') |